EP
KMTS

Essential Partners’s Kestra Medical Technologies KMTS Stock Holding History

Essential Partners’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65K Sell
104
-1
-1% -$21 ﹤0.01% 1856
2026
Q1 		$2.09K Buy
105
+1
+1% +$24 ﹤0.01% 1991
2025
Q4 		$2.76K Hold
104
– – ﹤0.01% 1689
2025
Q3 		$2.47K Buy
+104
New +$1.86K ﹤0.01% 1721

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Essential Partners's KMTS Position: Q2 2026 in Review

Essential Partners reduced its Kestra Medical Technologies (KMTS) stake by 0.95% in Q2 2026, selling an estimated $21 and leaving 104 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Essential Partners first reported a position in KMTS in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.76K in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Essential Partners held 104 shares of Kestra Medical Technologies worth $2.65K as of Q2 2026.
  • Essential Partners sold 1 Kestra Medical Technologies share in Q2 2026, an estimated $21.
  • Kestra Medical Technologies made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1856 holding.
  • Essential Partners first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Kestra Medical Technologies position peaked at $2.76K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.